AKT1 and Cognitive impairment: These protective effects include modulation of the intersection between insulin/AKT/GSK-3β and canonical/non-canonical Wnt/β-catenin trajectories, as well as mitigation of neuroinflammation with subsequent improvement in memory and cognitive defects, as well as restoration of the hippocampal histological profile.